PlenOptika

PlenOptika is a medical technology company dedicated to eliminating preventable vision loss globally. Founded from research at MIT, the company focuses on providing accessible and high-quality vision assessments, particularly in underserved populations and developing countries. The flagship product, QuickSee™, is a handheld wavefront autorefractor that combines affordable optical components with advanced machine learning and AI technology. This device allows for fast and reliable vision assessments in various settings, from urban clinics to remote villages. QuickSee has been validated through over 20 clinical studies, demonstrating its effectiveness in prescribing eyeglasses comparable to traditional methods. PlenOptika's technology has impacted more than 5 million patients across over 45 countries. Headquartered in Boston, Massachusetts, PlenOptika collaborates with eye care professionals, NGOs, and research institutions to enhance its technology and strategy. The company is committed to improving vision care and addressing the global burden of uncorrected refractive error.

• Employees 23
• Founded 2014
• Total Funding $50383